VITEK COMPACT PRO receives FDA 510(k) Clearance
bioMérieux has received FDA 510(k) clearance for VITEK COMPACT PRO, aimed at improving diagnostics in clinical and industrial laboratories.
Read MorePosted by Chris Wolski | Mar 18, 2025 | Immunoassay |
bioMérieux has received FDA 510(k) clearance for VITEK COMPACT PRO, aimed at improving diagnostics in clinical and industrial laboratories.
Read MorePosted by Chris Wolski | Mar 12, 2025 | Sequencing Systems |
Children’s Hospital Colorado’s new in-house whole-genome sequencing lab is revolutionizing patient care by making genetic testing faster.
Read MorePosted by Chris Wolski | Mar 10, 2025 | Cancer |
A new study highlights the role of tsRNAs as potential biomarkers and therapeutic targets for digestive tract diseases.
Read MorePosted by Chris Wolski | Mar 10, 2025 | Kidney Disease |
A new review highlights the critical role of lncRNAs in the development, diagnosis, and treatment of acute kidney injury (AKI) and CKD.
Read MorePosted by Chris Wolski | Mar 6, 2025 | Unknown Origin & Other Cancer Types |
A study highlights the role of exRNA in head and neck cancers (HNCs), emphasizing their potential as non-invasive biomarkers for diagnosis.
Read More